Details

Autor(en) / Beteiligte

• Anwar, Tasneem
• Ismail, Saba
• Parvaiz, Fahed
• Abbasi, Sumra Wajid
• A Al-Abbasi, Fahad
• M Alghamdi, Amira
• Al-Regaiey, Khalid
• Ul-Haq, Asad
• Kaleem, Imdad
• Bashir, Shahid
• Waheed, Yasir
• Nasrallah, Gheyath K.

Titel

Computational design of experimentally validated multi-epitopes vaccine against hepatitis E virus: An immunological approach

Ist Teil von

• PloS one, 2023-12, Vol.18 (12), p.e0294663-e0294663

Ort / Verlag

United States: Public Library of Science

Erscheinungsjahr

2023

Quelle

EZB Electronic Journals Library

Beschreibungen/Notizen

• Hepatitis E virus (HEV) is one of the leading acute liver infections triggered by viral hepatitis. Patients infected with HEV usually recover and the annual death rate is negligible. Currently, there is no HEV licensed vaccine available globally. This study was carried out to design a multi-epitope HEV peptide-based vaccine by retrieving already experimentally validated epitopes from ViPR database leading to epitope prioritization. Epitopes selected as potential vaccine candidates were non-allergen, immunogenic, soluble, non-toxic and IFN gamma positive. The epitopes were linked together by AAY linkers and the linker EAAAK was used to join adjuvant with epitopes. Toll-like receptor (TLR)-4 agonist was used as an adjuvant to boost efficacy of the vaccine. Furthermore, codon optimization followed by disulfide engineering was performed to analyse the designed vaccine's structural stability. Computational modeling of the immune simulation was done to examine the immune response against the vaccine. The designed vaccine construct was docked with TLR-3 receptor for their interactions and then subjected to molecular dynamic simulations. The vaccine model was examined computationally towards the capability of inducing immune responses which showed the induction of both humoral and cell mediated immunity. Taken together, our study suggests an In-silico designed HEV based multi-epitope peptide-based vaccine (MEPV) that needs to be examined in the wet lab-based data that can help to develop a potential vaccine against HEV.